Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

about

Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery

P2860

Q57072939-2C9FEE58-9BEC-41C6-ABB5-B81DAC98F865

P2860

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

Item

http://www.wikidata.org/entity/Q47965250

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

@en

Pharmacogenetics of aldo-keto reductase 1C

@nl

type

Item

label

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

@en

Pharmacogenetics of aldo-keto reductase 1C

@nl

prefLabel

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

@en

Pharmacogenetics of aldo-keto reductase 1C

@nl

P1476

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

@en

P2093

Osama Y Alshogran

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetics, pharmacogenomics, and individualized medicine

Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin

Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily

Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study

Crystal structure of human prostaglandin F synthase (AKR1C3)

Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer

Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

Environmental epigenetics and its implication on disease risk and health outcomes

Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk

Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells

P304

1063-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425255.2017.1376648

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28871815

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

about

P2860

P2860

Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698